- Home
- WTI vs RVNC Comparison
WTI vs RVNC Comparison
Compare WTI & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTI
- RVNC
- Stock Information
- Founded
- WTI 1983
- RVNC 1999
- Country
- WTI United States
- RVNC United States
- Employees
- WTI N/A
- RVNC N/A
- Industry
- WTI Oil & Gas Production
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- WTI Energy
- RVNC Health Care
- Exchange
- WTI Nasdaq
- RVNC Nasdaq
- Market Cap
- WTI 350.3M
- RVNC 292.5M
- IPO Year
- WTI 2005
- RVNC 2014
- Fundamental
- Price
- WTI $2.03
- RVNC $6.58
- Analyst Decision
- WTI Strong Buy
- RVNC Buy
- Analyst Count
- WTI 1
- RVNC 11
- Target Price
- WTI $7.80
- RVNC $11.38
- AVG Volume (30 Days)
- WTI 1.1M
- RVNC 8.3M
- Earning Date
- WTI 08-06-2024
- RVNC 08-08-2024
- Dividend Yield
- WTI 1.98%
- RVNC N/A
- EPS Growth
- WTI N/A
- RVNC N/A
- EPS
- WTI N/A
- RVNC N/A
- Revenue
- WTI $558,294,000.00
- RVNC $251,178,000.00
- Revenue This Year
- WTI $11.10
- RVNC $20.12
- Revenue Next Year
- WTI $3.76
- RVNC $34.75
- P/E Ratio
- WTI N/A
- RVNC N/A
- Revenue Growth
- WTI N/A
- RVNC 40.23
- 52 Week Low
- WTI $1.98
- RVNC $2.30
- 52 Week High
- WTI $4.47
- RVNC $17.59
- Technical
- Relative Strength Index (RSI)
- WTI 37.39
- RVNC 75.90
- Support Level
- WTI $1.98
- RVNC $6.55
- Resistance Level
- WTI $2.35
- RVNC $6.65
- Average True Range (ATR)
- WTI 0.07
- RVNC 0.03
- MACD
- WTI -0.03
- RVNC -0.10
- Stochastic Oscillator
- WTI 11.63
- RVNC 36.36
About WTI W&T Offshore Inc.
W&T Offshore Inc is an oil and gas exploration and production company. The company's exploration operations are focused in the Gulf of Mexico, where it drills for oil and gas. The company engages in both deepwater drilling and shallow-water shelf drilling. W&T Offshore extracts crude oil, natural gas, and natural gas liquids, which are then sold directly at the wellhead. Overall, crude oil accounts for the majority of company's revenue, with natural gas accounting for a much smaller portion.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.